T. Shiroshita

Interleukin‐10 expression and cytotoxic‐T‐cell response in Epstein‐Barr‐virus‐associated nasopharyngeal carcinoma

K. Ohshima, M. Kikuchi, M. Yao, 1997, International journal of cancer.

Successful treatment of diffuse esophageal spasm by peroral endoscopic myotomy.

Y. Yamashita, H. Inoue, H. Minami, 2013, Gastrointestinal endoscopy.

Spindle cell carcinoma of the breast: A case report and an immunohistochemical study including p53 and Ki‐67 expression

H. Iwasaki, S. Ikeda, Hiroshi Nakamura, 1997, Pathology international.

Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects

Y Kumagai, H Yuasa, H. Kusuhara, 2011, Clinical pharmacology and therapeutics.

Restoration of Train-of-Four Ratio with Neostigmine After Insufficient Recovery with Sugammadex in a Patient with Myasthenia Gravis.

K. Nitahara, K. Higa, T. Shiroshita, 2013, A & A case reports.

Number of metastasis-positive lymph node stations is a simple and reliable prognostic factor following surgery in patients with esophageal cancer

Y. Yamashita, S. Takeno, K. Kawahara, 2012, Experimental and therapeutic medicine.

Successful Treatment of Septic Shock due to Spontaneous Esophageal Perforation 96 Hours after Onset by Drainage and Enteral Nutrition

Y. Yamashita, S. Takeno, Toru Miyake, 2014, Case Reports in Gastroenterology.

Long-term survival after excision of a giant esophageal gastrointestinal stromal tumor with imatinib mesylate resistance: report of a case

Y. Yamashita, S. Takeno, K. Kawahara, 2014, Surgery Today.

Long-term Outcome of Surgical Treatment for Anal Crohn's Disease

K. Futami, T. Tomiyasu, Daijiro Higashi, 2005 .

Free jejunal graft repair after pharyngolaryngo-esophagectomy-risk factor analysis for postoperative dysphagia.

Y. Yamashita, T. Nakagawa, T. Shiraishi, 2014, Annals of thoracic and cardiovascular surgery : official journal of the Association of Thoracic and Cardiovascular Surgeons of Asia.

Effects of a MATE Protein Inhibitor, Pyrimethamine, on the Renal Elimination of Metformin at Oral Microdose and at Therapeutic Dose in Healthy Subjects

H. Kusuhara, Y. Sugiyama, Y. Moriyama, 2011, Clinical pharmacology and therapeutics.